Assessing the prevalence of neutralizing antibodies (NAbs) to SARS-CoV-2 during three years of the COVID-19 pandemic

MLA

Marina dos Santos Barreto, et al. “Assessing the Prevalence of Neutralizing Antibodies (NAbs) to SARS-CoV-2 during Three Years of the COVID-19 Pandemic.” Biochemistry and Biophysics Reports, vol. 41, no. 101903-, Mar. 2025. EBSCOhost, https://doi.org/10.1016/j.bbrep.2024.101903.

APA

Marina dos Santos Barreto, Ronaldy Santana Santos, Eloia Emanuelly Dias Silva, Deise Maria Rego Rodrigues Silva, Pedro Henrique Macedo Moura, Pamela Chaves de Jesus, Jessiane Bispo de Souza, Lucas Alves da Mota Santana, Adriana Gibara Guimarães, & Lysandro Pinto Borges. (2025). Assessing the prevalence of neutralizing antibodies (NAbs) to SARS-CoV-2 during three years of the COVID-19 pandemic. Biochemistry and Biophysics Reports, 41(101903-). https://doi.org/10.1016/j.bbrep.2024.101903

Chicago

Marina dos Santos Barreto, Ronaldy Santana Santos, Eloia Emanuelly Dias Silva, Deise Maria Rego Rodrigues Silva, Pedro Henrique Macedo Moura, Pamela Chaves de Jesus, Jessiane Bispo de Souza, Lucas Alves da Mota Santana, Adriana Gibara Guimarães, and Lysandro Pinto Borges. 2025. “Assessing the Prevalence of Neutralizing Antibodies (NAbs) to SARS-CoV-2 during Three Years of the COVID-19 Pandemic.” Biochemistry and Biophysics Reports 41 (101903-). doi:10.1016/j.bbrep.2024.101903.